Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140

GSK Investigational Site, Brussels

GSK Investigational Site, Charleroi

GSK Investigational Site, New York

GSK Investigational Site, Washington D.C.

GSK Investigational Site, Hamburg

GSK Investigational Site, Baltimore

GSK Investigational Site, Hampton

GSK Investigational Site, Lynchburg

GSK Investigational Site, Atlanta

GSK Investigational Site, Tarzana

GSK Investigational Site, Hanover

GSK Investigational Site, Orlando

GSK Investigational Site, Hollywood

GSK Investigational Site, Fort Lauderdale

GSK Investigational Site, Plantation

GSK Investigational Site, Oakland Park

GSK Investigational Site, Tampa

GSK Investigational Site, Düsseldorf

GSK Investigational Site, Akron

GSK Investigational Site, Cologne

GSK Investigational Site, Minneapolis

GSK Investigational Site, Chicago

GSK Investigational Site, Dallas

GSK Investigational Site, Houston

GSK Investigational Site, Austin

GSK Investigational Site, Tucson

GSK Investigational Site, Las Vegas

GSK Investigational Site, Los Angeles

GSK Investigational Site, Long Beach

GSK Investigational Site, Laguna Beach

GSK Investigational Site, Oakland

GSK Investigational Site, Portland

GSK Investigational Site, Portland

GSK Investigational Site, Spokane

GSK Investigational Site, Glastonbury

GSK Investigational Site, Norwalk

GSK Investigational Site, New Orleans

GSK Investigational Site, Boston

GSK Investigational Site, East Orange

GSK Investigational Site, Newark

GSK Investigational Site, Toronto

GSK Investigational Site, Copenhagen